Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$506K Buy
21,003
+3,310
+19% +$86.6K 0.03% 211
2026
Q1
$497K Buy
17,693
+1,186
+7% +$31.6K 0.04% 201
2025
Q4
$411K Buy
16,507
+2,142
+15% +$54K 0.03% 202
2025
Q3
$366K Sell
14,365
-1,399
-9% -$34.5K 0.03% 182
2025
Q2
$382K Buy
15,764
+3,094
+24% +$72.2K 0.04% 166
2025
Q1
$321K Buy
+12,670
New +$332K 0.03% 170
2024
Q4
Sell
-7,766
Closed -$225K 227
2024
Q3
$225K Buy
7,766
+402
+5% +$11.7K 0.02% 191
2024
Q2
$206K Buy
+7,364
New +$203K 0.02% 195
2023
Q4
Sell
-6,267
Closed -$208K 193
2023
Q3
$208K Buy
6,267
+29
+0.5% +$1.03K 0.03% 162
2023
Q2
$229K Sell
6,238
-5,398
-46% -$210K 0.03% 157
2023
Q1
$475K Sell
11,636
-701
-6% -$30.3K 0.07% 102
2022
Q4
$632K Sell
12,337
-35
-0.3% -$1.68K 0.12% 86
2022
Q3
$541K Buy
12,372
+520
+4% +$25.3K 0.12% 91
2022
Q2
$622K Buy
11,852
+949
+9% +$48.4K 0.16% 79
2022
Q1
$564K Buy
+10,903
New +$566K 0.14% 89
2021
Q3
$451K Buy
+10,479
New +$464K 0.16% 63
2021
Q1
$379K Buy
10,467
+1,162
+12% +$41.3K 0.13% 104
2020
Q4
$343K Buy
+9,305
New +$341K 0.14% 94

Other funds holding PFE

MBL Wealth's PFE Position: Q2 2026 in Review

MBL Wealth increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $86.6K and bringing the position to 21,003 shares worth $506K. The position accounts for 0.03% of the portfolio, ranked #211.

MBL Wealth first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $632K in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MBL Wealth held 21,003 shares of Pfizer worth $506K as of Q2 2026.
  • MBL Wealth bought 3,310 Pfizer shares in Q2 2026, an estimated $86.6K.
  • Pfizer made up 0.03% of MBL Wealth's portfolio in Q2 2026, its #211 holding.
  • MBL Wealth first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
  • MBL Wealth's Pfizer position peaked at $632K in Q4 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.